COMPASS Pathways (CMPS) has issued an announcement.
Gino Santini has been appointed as the new Chairman and a Class I director of the Company’s board, starting September 3, 2024, with his tenure extending until the next annual general meeting where he can be re-elected. Santini brings a wealth of experience as a senior advisor and board member of various pharmaceutical and biotech companies, drawing on a distinguished career at Eli Lilly. He will receive compensation in line with the Company’s policies, including stock options and cash retainers for his roles on the board and specific committees.
For detailed information about CMPS stock, go to TipRanks’ Stock Analysis page.
